A special shout-out to our CAMRIS team members supporting the Walter Reed Army Institute of Research’s Pilot Bioproduction Facility (PBF)! Your dedication to excellence in cGMP processes has been pivotal in bridging cutting-edge army medical, inter-agency, and private industry research into cGMP processes released for clinical trials. Thank you for your support and for your dedication to driving the development of vaccines and therapeutics for infectious disease threats. Keep up the amazing work!
CAMRIS’ Post
More Relevant Posts
-
Business Development Executive | Contract Research Organization | Drug Discovery & Development
Southern Research is one of the few CROs in the US that can work with highly pathogenic agents. From SARS-CoV-2, RSV, MPox, and HPAI, we have the experience to support your infectious disease programs from discovery to clinic. This publication illustrates our unique capabilities to help advance your programs! Southern Research #infectiousdisease #researchcapabilities
After playing a pivotal role in the rapid response to SARS-CoV-2, we continue to establish ourselves as leaders in pandemic preparedness. Check out our latest publication on Nature.com, which outlines our readiness to offer vital contract research services to organizations developing vaccines and therapeutics for emerging pathogens. Our BSL-3 facilities and effective study teams make us an ideal fit to help move your latest program forward efficiently. https://lnkd.in/ewP-2u-h
-
-
We are pleased to announce the completion of enrollment in our Phase I trial of our vaccine candidate targeting human cytomegalovirus (#HCMV). This milestone marks a significant step forward in our clinical development program as we assess our innovative vaccine platform designed to target infectious and chronic diseases. For details, see our press release: https://lnkd.in/etxwaXun #ClinicalTrials #VaccineDevelopment #InnovativeMedicine #InfectiousDiseases #ChronicDiseases #Cytomegalovirus #Biotech #DrugDevelopment #MedicalResearch #Immunogenicity #VaccineResearch
-
-
NanoViricides, Inc. (NYSE-A:NNVC) told investors it believes that the strong safety and tolerability of its NV-CoV-2 oral drug products containing the active ingredient NV-387 shows that they have implications beyond COVID. NV-387 is an ultra-broad-spectrum antiviral nanomedicine that was designed by copying a common host-side chemical signature used by viruses to infect and cause disease in humans and animals, the company said. The company recently reported positive safety data from a Phase 1a/1b trial of NV-387 in humans. Not only did no patients in the study experience any adverse events, but NV-387 demonstrated early signs of effectiveness against respiratory viruses, including coronaviruses and respiratory syncytial virus (RSV). #NYSEA #NNVC More at #Proactive #ProactiveInvestors http://ow.ly/numB105eUyf
-
Step into the future of healthcare with the booming global antibacterial vaccine market! 🌍💉 🚀 Expected to grow from $22 Bn currently to $40 Bn by 2030 Witnessing revolutionary advancements in preventing life-threatening infections, due to increased awareness and investments ⛽Significant regulatory milestones in the US and EU approaching for #Merck, #GSK, and #Sanofi, thus positioning these players in the run for a piece of the antibacterial vaccine market commercial opportunity 🚀 The imminent launch of #Pfizer’s adolescent vaccine in the US exemplifies the industry's dedication to combating infectious diseases, and Pfizer’s push to expand their vaccine portfolio strength Join us as we witness a healthier tomorrow. 💉Stay informed with us in this vital sector! #HealthRevolution #VaccineAdvancements #Antibacterialvaccines #Pfizer #GSK #Sanofi #Merck
-
You don't detect DNA during your viral vector production? Great, but what about the chromatin? Have you ever checked? Sign up for our webinar and learn how to remove all the DNA from your product, including the one in the form of chromatin.
Who doesn't want #viralvector manufacturing results like this➡️? Join webinar👇 with scientists presenting data from acib, a non-profit internationally recognized research center, and ArcticZymes. Learn how to elevate purity and yield and reduce costs—achieving more with less nuclease. Embrace clarity & innovation from the #inventors of salt active nucleases. ✨Register for the on-demand or live #webinar Sep 19th here 🚀This webinar will change the way you see #DNAremoval https://lnkd.in/dfvwgZWy acib GmbH #bioprocessing #genetherapy #therapeutics #vaccines #oncolyticviruses #lentivirus #AAV #adenoassociatedvirus
-
A new article from Science Magazine covers our recently released report on the future state of #smallpox medical countermeasures. The report presents findings and conclusions that emphasize the need for investment in improving smallpox vaccines, diagnostics, and therapeutics. Access the report to learn more: https://ow.ly/Jgxi50R4kKh
Smallpox may be gone but U.S. should better prepare for its return, report says
science.org
-
INTREPID Alliance Releases Review of #Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in #Pandemic #Preparedness https://lnkd.in/dimK6q4i
INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness
theindustrial.in
-
Ready to start your week with inspiration? Join us for a free, digital event that affords you a unique opportunity to hear from experts in the field of hepatitis treatment regarding the remarkable medical triumph over this disease! Click below to register, the webinar starts in one hour 🚨 #medicalaffairs #medicinesdevelopment #webinar #GMDPacademy #digitallearning #pharmaceuticals #hepatitistreatment #viralhepatitis
Welcome! You are invited to join a webinar: The Successful Fight Against Hepatitis. After registering, you will receive a confirmation email about joining the webinar.
us02web.zoom.us
-
Who doesn't want #viralvector manufacturing results like this➡️? Join webinar👇 with scientists presenting data from acib, a non-profit internationally recognized research center, and ArcticZymes. Learn how to elevate purity and yield and reduce costs—achieving more with less nuclease. Embrace clarity & innovation from the #inventors of salt active nucleases. ✨Register for the on-demand or live #webinar Sep 19th here 🚀This webinar will change the way you see #DNAremoval https://lnkd.in/dfvwgZWy acib GmbH #bioprocessing #genetherapy #therapeutics #vaccines #oncolyticviruses #lentivirus #AAV #adenoassociatedvirus
-
Pfizer has a developed second generation antiviral (Ibuzatrelvir) to treat COVID infection, without the need for ritonavir found in #Paxlovid. Here we provide structural insight into the potency of this drug for SARS-CoV2 and MERS Main proteases #antivirals
A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV
pubs.acs.org
